Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion.

Huang TH, Wu F, Loeb GB, Hsu R, Heidersbach A, Brincat A, Horiuchi D, Lebbink RJ, Mo YY, Goga A, McManus MT.

J Biol Chem. 2009 Jul 3;284(27):18515-24. doi: 10.1074/jbc.M109.006676. Epub 2009 May 6.

PMID:
19419954
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

MicroRNAs in breast cancer pathogenesis.

Götte M.

Minerva Ginecol. 2010 Dec;62(6):559-71. Review.

PMID:
21079577
[PubMed - indexed for MEDLINE]
3.

HER2 overexpression and cancer targeting.

Wang SC, Hung MC.

Semin Oncol. 2001 Oct;28(5 Suppl 16):115-24. Review.

PMID:
11706403
[PubMed - indexed for MEDLINE]
4.

Monitoring the circulating levels of the HER2/neu oncoprotein in breast cancer.

Carney WP, Neumann R, Lipton A, Leitzel K, Ali S, Price CP.

Clin Breast Cancer. 2004 Jun;5(2):105-16. Review.

PMID:
15245613
[PubMed - indexed for MEDLINE]
5.

HER2/neu antisense targeting of human breast carcinoma.

Roh H, Pippin JA, Green DW, Boswell CB, Hirose CT, Mokadam N, Drebin JA.

Oncogene. 2000 Dec 11;19(53):6138-43. Review.

PMID:
11156527
[PubMed - indexed for MEDLINE]
Free Article
6.

When tumor suppressor TGFβ meets the HER2 (ERBB2) oncogene.

Chow A, Arteaga CL, Wang SE.

J Mammary Gland Biol Neoplasia. 2011 Jun;16(2):81-8. doi: 10.1007/s10911-011-9206-4. Epub 2011 Apr 6. Review.

PMID:
21590373
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The role of c-erbB-2/HER2/neu in breast cancer progression and metastasis.

Eccles SA.

J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):393-406. Review.

PMID:
12013529
[PubMed - indexed for MEDLINE]
8.

Role of miR-10b in breast cancer metastasis.

Ma L.

Breast Cancer Res. 2010;12(5):210. doi: 10.1186/bcr2720. Epub 2010 Oct 26. Review.

PMID:
21067538
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

The role of HER2 in early breast cancer metastasis and the origins of resistance to HER2-targeted therapies.

Freudenberg JA, Wang Q, Katsumata M, Drebin J, Nagatomo I, Greene MI.

Exp Mol Pathol. 2009 Aug;87(1):1-11. doi: 10.1016/j.yexmp.2009.05.001. Epub 2009 May 18. Review.

PMID:
19450579
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The oncogenic role of miR-155 in breast cancer.

Mattiske S, Suetani RJ, Neilsen PM, Callen DF.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1236-43. doi: 10.1158/1055-9965.EPI-12-0173. Epub 2012 Jun 26. Review.

PMID:
22736789
[PubMed - indexed for MEDLINE]
Free Article
11.

Identification of novel metastasis suppressor signaling pathways for breast cancer.

Minn AJ, Bevilacqua E, Yun J, Rosner MR.

Cell Cycle. 2012 Jul 1;11(13):2452-7. doi: 10.4161/cc.20624. Epub 2012 Jul 1. Review.

PMID:
22659842
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Role of miR-155 in breast cancer.

Wang J, Wu J.

Front Biosci (Landmark Ed). 2012 Jun 1;17:2350-5. Review.

PMID:
22652783
[PubMed - indexed for MEDLINE]
13.

Lipid biology of breast cancer.

Baumann J, Sevinsky C, Conklin DS.

Biochim Biophys Acta. 2013 Oct;1831(10):1509-17. doi: 10.1016/j.bbalip.2013.03.011. Epub 2013 Apr 2. Review.

PMID:
23562840
[PubMed - indexed for MEDLINE]
14.

Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?

Young MR, Santhanam AN, Yoshikawa N, Colburn NH.

Mol Interv. 2010 Apr;10(2):76-9. doi: 10.1124/mi.10.2.5. Review. No abstract available.

PMID:
20368367
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk